1. Garratty G. Immune hemolytic anemia caused by drugs. Expert opinion on drug safety. 2012;11(4):635-42.
2. Hoffman PC. Immune hemolytic anemia—selected topics. ASH Education Program Book. 2009;2009(1):80-6.
3. Barcellini W, Fattizzo B. How I treat warm autoimmune hemolytic anemia. Blood. 2021;137(10):1283-94.
4. Gupta S, Szerszen A, Nakhl F, Varma S, Gottesman A, Forte F, et al. Severe refractory autoimmune hemolytic anemia with both warm and cold autoantibodies that responded completely to a single cycle of rituximab: a case report. Journal of medical case reports. 2011;5(1):1-5.
5. Hill A, Hill QA. Autoimmune hemolytic anemia. Hematology. 2018;2018(1):382-9.
6. Barcellini W, Fattizzo B. How I treat warm autoimmune hemolytic anemia. Blood, The Journal of the American Society of Hematology. 2021;137(10):1283-94.
7. Hill QA, Stamps R, Massey E, Grainger JD, Provan D, Hill A, et al. The diagnosis and management of primary autoimmune haemolytic anaemia. British Journal of Haematology. 2017;176(3):395-411.
8. Barcellini W, Giannotta J, Fattizzo B. Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures. Expert Review of Hematology. 2020;13(6):585-97.
9. Gertz MA. Cold hemolytic syndrome. ASH Education Program Book. 2006;2006(1):19-23.
10. Kulpa J, Skrabs C, Simanek R, Valent P, Panzer S, Lechner K, et al. Probability of remaining in unsustained complete remission after steroid therapy withdrawal in patients with primary warm-antibody reactive autoimmune hemolytic anemia. Wiener klinische Wochenschrift. 2016;128(7-8):234-7.
11. Roumier M, Loustau V, Guillaud C, Languille L, Mahevas M, Khellaf M, et al. Characteristics and outcome of warm autoimmune hemolytic anemia in adults: New insights based on a single‐center experience with 60 patients. American journal of hematology. 2014;89(9):E150-E5.
12. Barcellini W, Fattizzo B, Zaninoni A. Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives. Journal of blood medicine. 2019;10:265.
13. Petz LD. evaluation of patients with immune hemolysis. IMMUNOHEMATOLOGY-WASHINGTON DC-. 2004;20:167-76.
14. Jäger U, Barcellini W, Broome CM, Gertz MA, Hill A, Hill QA, et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. Blood reviews. 2020;41:100648.
15. Barcellini W, Fattizzo B. The changing landscape of autoimmune hemolytic anemia. Frontiers in Immunology. 2020;11:946.
16. Agha RA, Franchi T, Sohrabi C, Mathew G, Kerwan A, Thoma A, et al. The SCARE 2020 guideline: updating consensus surgical CAse REport (SCARE) guidelines. International Journal of Surgery. 2020;84:226-30.
17. Fattizzo B, Zaninoni A, Nesa F, Sciumbata VM, Zanella A, Cortelezzi A, et al. Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias. American Journal of Hematology. 2015;90(8):E149-E51.
18. Kashyap A, Kashyap S. Haemolytic anaemia due to metformin. Postgraduate medical journal. 2000;76(892):125-6.
19. Kleinman S, Nelson R, Smith L, Goldfinger D. Positive direct antiglobulin tests and immune hemolytic anemia in patients receiving procainamide. New England Journal of Medicine. 1984;311(13):809-12.
20. Worlledge SM, Blajchman M. The autoimmune haemolytic anaemias. British journal of haematology. 1972;23:61-9.
21. EVANS RS, WEISER RS. The serology of autoimmune hemolytic disease: Observations on forty-one patients. AMA archives of internal medicine. 1957;100(3):371-99.
22. Chaplin Jr H. Clinical usefulness of specific antiglobulin reagents in autoimmune hemolytic anemias. Progress in hematology. 1973;8:25-49.
23. Segel GB, Lichtman MA. Direct antiglobulin (“Coombs”) test-negative autoimmune hemolytic anemia: a review. Blood Cells, Molecules, and Diseases. 2014;52(4):152-60.
24. Ben-Izhak O, Shechter Y, Tatarsky I. Direct antiglobulin test (Coombs test) association with autoimmune hemolytic anemia. Harefuah. 1984;107(11):351-3.
25. Kamesaki T, Kajii E. A comprehensive diagnostic algorithm for direct antiglobulin test-negative autoimmune hemolytic anemia reveals the relative ratio of three mechanisms in a single laboratory. Acta haematologica. 2018;140:10-7.
26. Reynaud Q, Durieu I, Dutertre M, Ledochowski S, Durupt S, Michallet A-S, et al. Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies. Autoimmunity Reviews. 2015;14(4):304-13.
27. Fattizzo B, Michel M, Zaninoni A, Giannotta JA, Guillet S, Frederiksen H, et al. Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: A multicenter international study. Haematologica. 2021;106(2):622.